NC525
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NC525, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms [Phase 1]